This study was designed to characterize muscarinic acetylcholine receptors (mAChRs) in primary cultured Sertoli cells from 30-d-old rats. RT-PCR was performed, and five PCR products corresponding to m1-m5 mAChR mRNA subtypes were detected in these cells. Ribonuclease protection assay further confirmed the presence of protected products for m1, m2, m3, and m4 mAChR transcripts. Radioligand binding studies and the analysis of changes in intracellular signaling pathways after cell exposure to carbachol were performed to study mAChRs at the protein level. Scatchard analysis revealed one single class of I N THE LAST two decades, it has become increasingly evident that disturbances of the hypothalamic-pituitarygonadal axis account for male infertility (1). In an attempt to clarify the pathophysiology of idiopathic male infertility and develop new methods for male contraception, researches have focused on local regulators of intratesticular events (2).
I N THE LAST two decades, it has become increasingly evident that disturbances of the hypothalamic-pituitarygonadal axis account for male infertility (1) . In an attempt to clarify the pathophysiology of idiopathic male infertility and develop new methods for male contraception, researches have focused on local regulators of intratesticular events (2) .
How the testis is involved in the regulation of its own dual functions of maintaining virility and fertility is still an open question. Testicular function depends on local cellular secretions and cellular interactions that are influenced by pituitary secretions of LH acting on Leydig cells and secretions of FSH acting on Sertoli cells (3) (4) (5) . Several studies have shown the importance of FSH in the control of Sertoli cell function; however, the male fertility is poorly affected in the absence of FSH. Male FSH␤ and FSH receptor knockout mice are fertile, despite having reduced testicular size and partial spermatogenic failure (6) . Inactivating point mutation in FSH receptor makes human females but not males completely infertile (7, 8) . These observations suggest the existence of other transduction pathways leading to the preservation of Sertoli cell function.
Efferent neurons supplying the rat testis originate in the pelvic ganglia and sympathetic chain (9) . Adrenergic and cholinergic nerve fibers innervate the capsule, vasculature, peripheral interstitium, and myoid cells of the rat testis (9 -11) . Regression of spermatogenesis was shown during the chronic testicular denervation in mature rats (12) , suggesting a neuronal control of spermatogenesis. Leydig and Sertoli cells are affect by neurotransmitters normally released from autonomic nervous system (13) (14) (15) (16) . Catecholamines stimulate cAMP production and aromatization of T to 17␤-E2 in cultured rat Sertoli cells (14 -16) . Such stimulatory effect is subject to controversy because other studies have suggested that these effects are observed in cultured rat and hamster Sertoli cells but not in freshly isolated cells from immature rats (17, 18) . However, in situ autoradiography on the rat testis sections showed that ␤-adrenoceptors are present in Sertoli cells (19) . Furthermore, it has been shown that freshly isolated rat Sertoli cells express ␤ 2 -adrenoceptors functionally coupled to adenylyl cyclase and tissue-type plasminogen activator stimulation (20, 21) and that these characteristics are preserved in Sertoli cells in culture (21) .
Although Risley and Skrepetos (22) believed that the testis had no cholinergic fibers, later studies revealed acetylcholinesterase-containing fibers in the testicular capsule of several species of mammals, including monkey, rat, rabbit, and ram (10) . A direct involvement of the cholinergic system and testis cells was also described by Chakraborty and Nelson (23) , who detected the presence of cholinesterase during spermatid differentiation and spermatozoa maturation in mice testis, including the smooth-surfaced endoplasmic reticulum of Sertoli cells. Recently, molecules immunologically related to acetylcholinesterase were detected mainly in the interstitial and peritubular compartment of the testis from rats in early stages of the development, but during maturation they were found in Sertoli cells and in differentiating germ cells (24) . The observed cellular and subcellular dis-tribution of acetylcholinesterase could readily account for a cholinergic control mechanism in Sertoli cells. In fact, carbachol, a cholinergic agonist, inhibits FSH-induced cAMP accumulation in cultured Sertoli cells from immature hamsters (25) and T secretion by purified rat Leydig cells (26) . Thus, although not directly innervated by the sympathetic and parasympathetic nervous system, testicular cells are subject to regulation by neurotransmitters normally released from these systems.
Muscarinic acetylcholine receptors (mAChRs) exist in multiple subtypes, denoted as M 1 , M 2 , M 3 , M 4 , and M 5 , which are encoded by five distinct but related genes (m1-m5) (27) (28) (29) (30) (31) 29 -32) . The aim of this work was to characterize the expression of mAChR subtypes at mRNA and protein level in rat Sertoli cells.
Materials and Methods

Cell culture
Primary Sertoli cell cultures were obtained from 30-d-old male Wistar rats, housed in the Animal Facility at Instituto Nacional de Farmacologia (INFAR), UNIFESP-EPM and kept on a 12-h light/12-h dark lighting schedule, at 20 C, with food and water ad libitum. The animals were euthanized using the guidelines for the care and use of laboratory animal, approved by the Research Committee from UNIFESP-Escola Paulista de Medicina. The testes were removed and decapsulated. Sertoli cells were prepared as previously described (33) . Cells were plated at a density of approximately 3 ϫ 10 5 cells/ml in Ham's F12/DMEM (F-12/DME 1:1) containing 3.6 g/liter HEPES, 1.2 g/liter NaHCO 3 , and 0.02 g/liter gentamicin (pH 7.2-7.4) at 35 C. The cells were grown in a humidified atmosphere of 95% air/5% CO 2 at 35 C. After 24 h, the medium was changed to F12/DME supplemented with 10 g/ml insulin, 10 g/ml transferrin, 10 ng/ml sodium selenite and 10 ng/ml epidermal growth factor and the cells were grown for another 3 d. At this stage, the cells were 90 -95% confluent and the percentage of viable cells in each culture, as determined by trypan blue exclusion, was more than 90%. Over 93% of the cells were identified as Sertoli cells by morphological study. At 30 d, the Sertoli cell proliferation in rats ceases (34, 35) and the androgen-binding protein secretion in cultured Sertoli cells treated with insulin, transferrin and epidermal growth factor is 2-fold higher than that obtained in cells from 19-to 25-d-old rats (36) . Thus, this culture system allows the study of nonhormonal factors that control Sertoli cell secretory activity.
RNA isolation
Sertoli cells were cultured in 100-mm dishes as described before. Total RNA was extracted from Sertoli cells and from frozen rat brain and heart, as described by Chirgwin et al. (37) . Purification of poly(A)
ϩ RNA from Sertoli cell total RNA was performed by using oligo(dT)-cellulose column as described by Ausubel et al. (38) . RNA samples were then quantitated, using a spectrophotometer at 260/280 nm and stored at 70 C for later use.
RT-PCR analysis
RT-PCR was performed using SuperScript II RT kit preamplification system for first-strand cDNA synthesis (Life Technologies, Inc., Gaithersburg, MD), according to manufacturer's instructions. Reverse transcription (RT) of Sertoli cell poly(A) ϩ RNA (5 g) or total RNA from brain (5 g), using random hexamer primers (50 ng), was performed at 50 C in a total volume of 20 l. All primers and PCR conditions were tested using total RNA from rat brain because m1-m5 muscarinic receptor mRNA transcripts are known to be expressed in this tissue (31) . Reactions in the absence of RT were also included for each RNA tested to check for genomic contamination. The resulting cDNA (2. Primers against m1-m5 mAChR mRNA subtypes (39, 40) and against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (41) , used as an internal control, were synthesized in the Oligonucleotide Facility, University of North Carolina at Chapel Hill, and in the Department of Biophysics, UNIFESP-Escola Paulista de Medicina, Brazil. Primer sequence, corresponding base sites and the size of the PCR products (⌬) were as follows: m1 sense, 5Ј-CTG GTT TCC TTC GTT CTC TG-3Ј (593-612) and m1 antisense 5Ј-GCT GCC TTC TTC TCC TTG AC-3Ј (1233-1214) (⌬ 641); m2 sense, 5Ј-GGC AAG CAA GAG TAG AAT AAA-3Ј (633-653) and m2 antisense, 5Ј-GCC AAC AGG ATA GCC AAG ATT-3Ј (1184 -1164) (⌬ 552); m3 sense, 5Ј-GTG GTG TGA TGA TTG GTC TG-3Ј (591-610) and m3 antisense, 5Ј-TCT GCC GAG GAG TTG GTG TC-3Ј (1380 -1361) (⌬ 790); m4 sense, 5Ј-AGT GCT TCA TCC AGT TCT TGT CCA-3Ј (543-566) and m4 antisense, 5Ј-CAC ATT CAT TGC CTG TCT GCT TTG-3Ј (1052-1029) (⌬ 510); m5 sense, 5Ј-CTC ATC ATT GGC ATC TTC TCC A-3Ј (1199 -1220) and m5 antisense, 5Ј-GGT CCT TGG TTC GCT TCT CTG T-3Ј (1645-1628) (⌬ 451); and GAPDH, sense 5Ј-CGG GAA GCT TGT GAT CAA TGG-3Ј (258 -277) and GAPDH antisense 5Ј-GGC AGT GAT GCC ATG GAC TG-3Ј (614 -595) (⌬ 357).
Ribonuclease protection assays
RNA labeling. Linearized muscarinic receptor constructs, containing rat cDNA inserts for m1, m3, m4, and m5 in the antisense orientation, under the transcriptional control of SP6 RNA polymerase, were used to make antisense stranded RNA probes. Plasmids were kindly provided by Dr. Tom I. Bonner (Laboratory of Cell Biology, NIH, Bethesda, MD) and are described in Bonner et al. (27, 28) . A 594-bp PCR product, including a 552-bp mAChR rat m2 gene fragment in the antisense orientation under T7 RNA polymerase transcriptional control, was obtained in our laboratory. Specific m2 gene primers included a 21-bp T3 and a T7 promoter sequence at the 5Ј end of the sense and antisense primer, respectively, as follows: m2-T3 sense (AATTAACCCTCACTA-AAGGGAGGCAAGCAAGAGTAGAATAAA) and m2-T7 antisense (TAATACGACTCACTATAGGGAGCCAACAGGATAGCCAAGAATT) (RNA polymerase promoter sequence underlined). Linearized plasmid containing a 304-bp ␤-actin gene fragment in the antisense orientation under the transcriptional control of T7/SP6 promoter was obtained from Ambion, Inc. (Austin, TX). RNA probes were radiolabeled with [␣- 32 P]UTP (specific activity 800 Ci/mmol) using MAXIScript vitro transcription kit (Ambion, Inc.). Full-length probes were purified on an 8 m urea/5% acrylamide gel before use. Sizes (nucleotides) of full-length probes and protected fragments were as follows: m1 430/377, m2 577/552, m3 720/687, m4 563/519, m5 608/494, and ␤-actin 304/250, respectively. For each mAChR probe, the fraction of uridine available for radiolabeling was similar: m1, 27%; m2, 33%; m3, 27%; m4, 25%; and m5, 30%.
Hybridization. Hybridization of RNA probes to total sample RNA was performed by using an RPA III assay kit (Ambion, Inc.) according to manufacturer's instructions. Briefly, rat Sertoli cell (30 g), brain (10 g), and heart (10 g) total RNA were coprecipitated with radiolabeled probe (10 6 cpm). RNA from the heart was used as a positive control because m2 mAChR transcript subtype expression is more abundant in this tissue than in the brain (31) . Probe excess was confirmed in experiments with increasing amounts of total RNA. Pellet was resuspended in 10 l of hybridization solution and incubated at 65 C (m1, m3, m4, and ␤-actin probes) or 42 C (m2, m5, and ␤-actin probes) for 12-14 h. Unprotected labeled RNA was digested with 0.25 U/ml RNase A and 10 U/ml RNase T1 for 30 min at 37 C. Samples were precipitated, resuspended in loading buffer (95% formamide; 0.025% xylene cyanol; 0.025% bromophenol blue; 0.5 mm EDTA; 0.025% SDS), and separated by electrophoresis on a denaturing 8 m urea/6% polyacrylamide gel, followed by drying and exposure to XAR-5 film (Kodak Co., Rochester, NY) for 12-24 h at Ϫ70 C. Nucleotide sizes were determined on the gel by comparison with the 0.1-to 1.0-kb 32 P-RNA century marker template set (Ambion, Inc.). 
Intracellular cAMP assays
Sertoli cells were cultured in 6-well plates; 24 h before the experiments, the medium was changed to F12/DME without supplements, and cell treatments were performed in triplicates. Cells were initially incubated for 10 min at 35 C with medium containing isobutyl-methylxanthine (10 Ϫ3 m), and incubation was continued for another 5 min in the absence (basal level) and presence of increasing concentrations of forskolin (10 Ϫ6 to 5 ϫ 10 Ϫ5 m). Forskolin induced a concentration-dependent increase on intracellular cAMP accumulation in rat Sertoli cells. The maximum effect was observed with the concentration of 10 Ϫ5 m. Thus, subsequent experiments to test the effect of carbachol and mAChR antagonists were performed on cells stimulated with forskolin 10 Ϫ5 m. Cells were treated with forskolin (10 Ϫ5 m) for 5 min and then for 1 min with carbachol (10 Ϫ6 to 10 Ϫ3 m) in the absence and presence of one of the following mAChR antagonists: atropine, methoctramine, tropicamide, pirenzepine, and p-fluoro-hexahydro-sila-difenidol (pfHHSiD) (10 Ϫ7 m). These antagonists were added 2 min prior the incubation of cells with carbachol (42) . The effect of mAChR agonist and antagonist on cAMP basal level was also investigated. Reactions were stopped by cooling cells to 0 C. Cells were rinsed with ice-cold PBS, transferred to tubes by using 600 l 3% perchloric acid and mixed in a vortex for 4 min at 4 C. After neutralization with 30% sodium bicarbonate (pH 6.5-7.5), the homogenate was centrifuged (1000 ϫ g, 10 min, 4 C). The intracellular cAMP level was measured in the perchloric acid-soluble supernatant, using cAMP 3 H assay system kit (Amersham International, Little Chalfont, Buckinghamshire, UK) according to the manufacturer's instruction. The intracellular cAMP levels were expressed as picomole per milligram protein.
Measurement of total [ 3 H]inositol phosphates
Sertoli cells were cultured in 100-mm dishes; 24 h before the experiment, culture medium was replaced by 199 medium with Earle's salts containing 2.2 g/liter NaHCO 3 , 0.02 g/liter gentamicin, 0.29 g/liter glutamine (pH 7.2-7.4) and 5 Ci/ml of myo [ 3 H]inositol (specific activity 47.0 Ci/mmol) and kept at 35 C as previously described (43) . After labeling, cells were rinsed and kept in the medium described before for 30 min. Medium containing 10 mm LiCl was then added to cells and, after 30 min, cells were incubated in the absence (basal level) and presence of carbachol (10 Ϫ6 -10 Ϫ3 m) for 1 min. When mAChR antagonists were used (atropine, pirenzepine, pfHHSiD, and methoctramine, 10 Ϫ7 M), they were added 2 min before cell incubation with carbachol. ATP (10 Ϫ4 M, 1 min) was used as a positive control. Reactions were stopped by cooling cells to 0 C. The medium was removed and cells were scraped with 1 ml of cold NaOH (0.1 n) and transferred to tubes containing 0.5 ml of methanol/chloroform (1:1, vol/vol) and 0.5 ml H 2 O. Samples were mixed in vortex and centrifuged (1000 ϫ g, 4 min, 4C), as described by Fox et al. (44) . Aqueous phase was neutralized (pH 6.5-7.5) with 0.1 N HCl and the separation of total [ 3 H]inositol phosphates was performed as previously described by Ascoli et al. (45) with some modifications. Briefly, the aqueous layer was mixed to 1 ml anion-exchange resin (Dowex AG1-ϫ8, formate form, 200 -400 mesh) and allowed to equilibrate for 30 min at room temperature. After centrifugation (1000 ϫ g, 5 min, 4C), the resin was washed sequentially with 2 ml of 10 mm myo-inositol and 2 ml of 5 mm sodium tetraborate/60 mm sodium formate. Thereafter, 2 ml of 0.1 m formic acid/1 m ammonium formate were mixed to resin and incubated for 30 min at room temperature. The total [
3 H]inositol phosphates were eluted and placed in scintillation vials containing Insta-Gel XF scintillation liquid (Packard, Meriden, CT). The amount of radioactivity was determined in scintillation beta counter. Total [
3 H]inositol phosphates were expressed as dpm.
EMSA
Nuclear protein extract. Sertoli cells were cultured in 100-mm dishes; 24 h before the experiment, the medium was changed to F12/DME without supplements. Cells were incubated in the absence (control) and presence of carbachol (10 Ϫ4 m) or forskolin (10 Ϫ5 ) for 0.5-8 h. Reactions were stopped by cooling cells to 0 C. The medium was removed and cells were rinsed and scraped with ice-cold PBS. After centrifugation (2,700 ϫ g, 15 sec), cells were resuspended in 400 l lysis buffer [10 mm HEPES, pH 7.5; 10 mm KCl; 0.1 mm EDTA; 10% glycerol; 1 mm dithiothreitol (DTT); 0.1 mm phenylmethylsulfonyl fluoride (PMSF)] and kept for 15 min on ice. After adding 25 l of NP-40 (10%), samples were mixed for 10 sec in vortex and centrifuged (2,700 ϫ g, 30 sec, 4 C). The resultant pellet was washed with 100 l lysis buffer and centrifuged (2,700 ϫ g, 30 sec, 4 C). The nuclear pellet was resuspended in 50 -100 l nuclear extract buffer (10 mm HEPES, pH 7.0; 0.5 m KCl; 1 mm EDTA; 10% glycerol; 1 mm DTT; 0.1 mm PMSF). Tubes were kept at 4 C for 15 min in a rocking plate. Samples were then centrifuged (20,000 ϫ g, 5 min) and resultant supernatant (nuclear extract) dialyzed for 2 h (dialysis membrane 0.25 m, Millipore Corp., Bedford, MA) against the following buffer: 10 mm HEPES (pH 7.5) containing 25 mm KCl, 0.1 mm EDTA, 10% glycerol, 1 mm DTT, and 0.1 mm PMSF. Nuclear extract was aliquoted and stored at Ϫ70 C until use. Aliquots were removed for protein concentration determination.
Gel shift assay. Assays were performed by using the gel shift assay system (Promega Corp., Madison, WI) according to the manufacturer's instructions. Activator protein-1 (AP-1) double-strand oligonucleotide consensus sequence was 5Ј-CGCTTGATGAGTCAGCCGGAA-3Ј (factor binding site is underlined). Radiolabeled probe [
32 P]AP-1 was obtained by using [␥-
32 P]ATP (specific activity 3000 Ci/mmol) and T4 polynucleotide kinase. For DNA binding reactions, 15 g of nuclear extract were diluted in binding buffer [10 mm HEPES, pH 7.5; 50 mm KCl; 1 mm MgCl 2 ; 0.5 mm EDTA; 0.5 mm DTT; 0.01 g/l poly(dI-dC).poly(dI-dC) and 4% glycerol]. After 30-min incubation at room temperature, a 45-min incubation was performed in the presence of 20,000 cpm/reaction of [ 32 P]AP-1. Protein-DNA complexes were resolved by electrophoresis in a 6% polyacrylamide nondenaturing gel run at 150 V for 1 h at room temperature. The gel was dried and exposed to XAR-5 film (Kodak Co.) for 24 -48 h at Ϫ70 C. Autoradiograms were scanned and analyzed densitometrically. For competition studies, specific (AP-1 consensus sequence) or nonspecific (TF-IID consensus sequence) unlabeled doublestranded oligonucleotides were included in a 50-fold molar excess over the amount of radiolabeled probe. Unlabeled oligonucleotide was added to binding reaction 30 min before the addition of the radiolabeled AP-1 consensus oligonucleotide.
Protein assay
Protein concentration was determined with a protein assay (Bio-Rad Laboratories, Inc., (Richmond, CA) using BSA as standard.
Statistical analysis
Data were expressed as mean Ϯ sem. Statistical analysis was determined by one-way ANOVA followed by Newman-Keuls test for multiple range comparisons, or by t test to compare the differences in two groups (46) . P values Ͻ 0.05 were accepted as significant.
Drugs and reagents
Ham's F-12/DMEM (F-12/DME, 1:1) was purchased from Irvine Scientific (Santa Ana, CA). Collagenase/dispase was purchased from Roche Molecular Biochemicals (Mannheim, Germany). 
Results
Expression of mAChR mRNA subtypes in rat Sertoli cells
The effectiveness of m1-m5 mAChR subtype specific primers was checked by performing RT-PCR studies with total RNA from rat brain, used as positive control (Fig. 1A) . Specific products corresponding to the five mAChR transcript subtypes were detected (Fig. 1A) . GAPDH was used as a control for cDNA amplification. No products were detected when reverse transcriptase was omitted from RT-PCR reaction, demonstrating that amplified products are indeed from cDNA and not from genomic DNA contamination (data not shown). When RT-PCR was performed with poly (A) ϩ RNA from Sertoli cells, amplification of the five different mAChR subtypes was also detected (Fig. 1B) . Total RNA isolated from rat Sertoli cells was tested in ribonuclease protection assays to detect the steady-state of mAChR mRNA subtypes. Total RNA from rat brain was used as a positive control for the expression of m1, m3, m4, and m5 mAChR transcripts, and total RNA from rat heart was used to detect m2 mAChR mRNA expression. All protected products were visualized in the expected sizes when RNA from brain and heart was used (Fig. 2A) . When labeled cRNA probes were hybridized against total RNA from rat Sertoli cell, the presence of m1, m2, m3, and m4 mAChRprotected fragments were observed, with levels comparably lower than those observed in brain and heart (Fig. 2B) . In contrast to RT-PCR experiments, m5 mAChR-protected gene fragment was not detected in Sertoli cells in ribonuclease protected assays. The absence of m5 transcript in Sertoli cells by this technique was not owing to RNA quality, since ␤-actin expression was detected (Fig. 2B) . (Fig. 3 ). An analysis of five separate experiments, performed in triplicate, yielded a dissociation constant (K D ) of 1.78 Ϯ 0.32 nm and binding capacity (B max ) of 221 Ϯ 20 fmol/mg protein.
The binding of [ 3 H]QNB to rat Sertoli cells
Effect of carbachol and mAChR antagonists on forskolininduced intracellular cAMP accumulation
Although carbachol 10
Ϫ6 m did not change forskolininduced intracellular cAMP accumulation, increasing concentrations of the cholinergic agonist (10 Ϫ5 , 10 Ϫ4 , and 10 Ϫ3 m) elicited significant reductions on forskolin-induced intracellular cAMP accumulation (23%, n ϭ 6; 34%, n ϭ 5; and 41%, n ϭ 9; respectively) (Fig. 4A ).
Muscarinic antagonists were tested for their ability to antagonize the effect of carbachol (10 Ϫ3 m) on forskolin-induced intracellular cAMP accumulation (Fig. 4B) . Atropine (nonselective antagonist), methoctramine (M 2 /M 4 -selective), and tropicamide (M 4 -selective) (10 Ϫ7 m) reversed the effect of carbachol. However, pfHHSiD (M 3 /M 1 -selective) and pirenzepine (M 1 -selective) (10 Ϫ7 m) did not change the effect induced by carbachol (Fig. 4B) . The incubation of cells with carbachol and all mAChR antagonists tested, in the absence of forskolin, did not change the basal levels of cAMP in Sertoli cells (data not shown).
Effect of carbachol and mAChR antagonists on total [ 3 H]inositol phosphates accumulation
ATP (10
Ϫ4 m, 1 min), used as a positive control, increased Sertoli cells total [ 3 H]inositol phosphates content to 114.2% Ϯ 9.6 (n ϭ 6) above basal level. Carbachol induced an increase on total [ 3 H]inositol phosphates accumulation in Sertoli cells, reaching a maximum increase of 26.2% (n ϭ 6) above basal level with the concentration of 10 Ϫ4 m (Fig. 5A ). Figure 5B shows the effect of different muscarinic antagonists on total [ 
FIG. 2.
Ribonuclease protection assay for the identification of mAChR mRNA subtypes in rat brain, heart, and Sertoli cells. A, Total RNA from rat brain was used as a positive control for the expression of m1, m3, m4, and m5 mAChR transcripts. Total RNA from rat heart was used to detect m2 mAChR expression. B, Total RNA from Sertoli cells was tested for the presence of m1-m5 mAChR mRNA expression. ␤-Actin protected fragment is shown on the right. The sizes of protected fragments were: m1, 377; m2, 552; m3, 687; m4, 519; m5, 494; and ␤-actin, 250. Results are representative of three to five experiments. 
Effect of carbachol on AP-1 transcription factor
The induction of AP-1-DNA binding activity, through mAChR activation by carbachol, was studied in rat Sertoli cell by EMSA. With no receptor stimulation, Sertoli cells expressed very little binding of nuclear factor AP-1 to DNA (Fig. 6A, lanes 2 and 10) . When cells were incubated with forskolin, used as a positive control, a biphasic effect on AP-1-DNA binding activity was observed (Fig. 6A, lanes 3-8;  Fig. 6B ). There was an increase in AP-1-DNA complex after 30 min of incubation. After 1 h of exposure to forskolin, AP-1-DNA binding decreased, but a second peak of AP-1 binding activity was detected between 2 and 6 h of incubation (Fig. 6B) . When cells were stimulated with carbachol, the same biphasic effect on AP-1-DNA binding activity was observed (Fig. 6A, lanes 13-18; Fig. 6C ). Carbachol stimulated AP-1 binding after 30 min of incubation and, although after 1 h of stimulation the AP-1-DNA binding decreased, there was a second peak of stimulation, reaching a maximum binding after 6 h of stimulation. The specificity of AP1-DNA complex was confirmed because binding was blocked by the presence of molar excess of specific unlabeled oligonucleotide AP-1 but not by the presence of a nonspecific unlabeled oligonucleotide (Fig. 6A, lanes 11 and 12) .
Discussion
mAChRs are known to regulate numerous fundamental physiological processes, including the muscarinic actions of acetylcholine on peripheral effector tissues and central sensory, vegetative, and motor functions (47) (48) . In the male reproductive tract, the activation of mAChRs induces vasoactivity within the testes (49), sperm transport through the excurrent duct system (50), muscle contraction, secretion (51) (52) (53) , and cell proliferation (54) within the sex accessory glands. Studies with subtype-selective antibodies, in situ mRNA hybridization experiments, and RT-PCR have shown that m1-m5 mAChR subtypes are widely expressed throughout the central nervous system and peripheral tissues and that the expression of each subtype is tissue and specie dependent (29 -30, 55-57) . The present work shows evidence for the presence of mAChRs, at mRNA and protein level, in rat Sertoli cells, suggesting that the cholinergic neurotransmitter may play a role in the autocrine and/or paracrine regulation of testicular cells.
Molecular studies indicated that multiple mAChR mRNA subtypes are present in rat Sertoli cells. All five different mAChR subtypes were detected in Sertoli cells by RT-PCR. Ribonuclease protection assays further confirmed that m1-m4 transcripts are, in fact, expressed in Sertoli cells and that the relative distribution of these transcripts in Sertoli cells was less abundant when compared with the positive control rat brain and heart. Consideration should be given to the fact that m5 transcript was detected by RT-PCR but not by RPA studies. Similar result discrepancies have been reported in the literature in other systems, and could be related to the higher sensitivity of RT-PCR for transcript detection (58 -60) . Because molecular techniques indicated that different mAChR subtypes are present in rat Sertoli cells, radioligand binding and functional intracellular signaling studies were performed to confirm whether mAChRs were present at the protein level in Sertoli cell. Because the characterization of the M 5 receptor is still incomplete and taking into consideration the lack of selective antagonists for this mAChR subtype (30, 56 -57) , we have not further explored the possible expression of this transcript on Sertoli cell.
[ 3 H]QNB saturation binding studies indicated the presence of one class of high-affinity sites for QNB in Sertoli cells, with affinity comparable to other tissues (K D ϭ 0.02 to 5 nm) that express mAChRs such as epididymis (61) , prostate (62) (63) (64) , vas deferens (63), bladder (65, 66) , and corpus cavernosum (67 recently shown that a nonselective antibody against mAChRs localized mAChR-like molecules in Sertoli cells during rat development. Taken together, these results give support to the idea that mAChRs may have, in fact, a physiological role in Sertoli cells.
The multiplicity of signals affecting the Sertoli cells suggests that multiple second messengers are used to modulate the function of these cells. It is well known that FSH acts via adenylyl cyclase activation and that the subsequent rise in cAMP levels leads to the activation of cAMP-dependent protein kinases and in turn phosphorylate-specific protein substrates (4). Furthermore, FSH via formation of cAMP exerts inhibitory effects on the phosphoinositide turnover of immature rat Sertoli cells in culture (68) . Sertoli cells, like other cell types, are also regulated by agonists having the ability to block FSH and glucagon-stimulated cAMP formation, such as adenosine (69, 70) and acetylcholine (25) . In the present study, carbachol induced a concentration dependent decrease on intracellular cAMP accumulation in rat Sertoli cells, an effect reversed with M 2 /M 4 -selective mAChR antagonists such as methoctramine and tropicamide but not with M 1 /M 3 -selective mAChR antagonists such as pfHHSiD and pirenzepine. It is important to emphasize that the concentration of methoctramine and tropicamide used (10 Ϫ7 M) is in agreement with pK i values described for these antagonists in M 2 and M 4 mAChR subtypes (71, 72) . Thus, these results suggested that M 2 /M 4 mAChRs, linked to inhibition of intracellular cAMP accumulation, are present in rat Sertoli cells.
Quirk and Reichert (43) showed that, using AlF 4 Ϫ as a stimulus, immature rat Sertoli cells contain pertussis toxinsensitive, G protein-modulated phospholipase C activity. Monaco et al. (68) observed that an unidentified component of FBS provokes inositol phosphate accumulation in these cells. Furthermore, endothelin and ATP induced inositol phosphate accumulation in prepubertal rat Sertoli cells (73) . In the present study, besides the effect on cAMP, the stimulation of mAChRs with carbachol also induced an increase on total inositol phosphate content in rat Sertoli cells. Because this effect was antagonized by muscarinic antagonists such as pfHHSiD (M 3 /M 1 -selective) and pirenzepine (M 1 -selective) but not by methoctramine (M 2 /M 4 -selective), the results suggested that M 3 and/or M 1 mAChR subtypes are also present in rat Sertoli cell. Thus, mAChR activation in Sertoli cell is linked to both adenylyl cyclase inhibition (via M 2 and/or M 4 mAChR) and to phosphoinositide hydrolysis (via M 1 and/or M 3 mAChR).
The literature reports that mAChRs coupled to phospholipase C and phosphoinositide hydrolysis can mediate the induction of early genes as c-fos and AP-1 transcription factor complex in the rat brain and cerebellar cells (74 -76) . It is also known that cAMP targets the cAMP response element for induction of c-fos transcription in rat Sertoli cells (77) (78) (79) . Thus, the involvement of AP-1 transcription factor during stimulation of Sertoli cells with cholinergic agonist was tested in the present study. Our results showed that carbachol was able to induce a biphasic increase in AP-1-DNA binding activity. The same biphasic induction of AP-1-DNA binding activity has been described in endothelial cells exposed to shear stress (80) and in HeLa cells exposed to hypoxia (81) . Atropine (10 Ϫ7 m), a nonselective mAChR antagonist, blocked the increase in AP1-DNA binding activity induced by carbachol (data not shown). Further experiments with subtype selective antagonists will be necessary to elucidate which mAChR is in fact involved in the carbachol induced increase of AP-1-DNA binding activity in Sertoli cells. Because regulation of AP-1-DNA binding activity by different mechanisms is likely to play a central role in the control of complex biological processes like cell proliferation and differentiation (79, (82) (83) (84) , the results suggest that carbachol stimulation trigger different intracellular signaling pathways, which in turn modulate gene expression on Sertoli cells.
Heterogeneity of mAChR subtypes is described in the literature in different species and tissues in the male reproductive tract by different pharmacological approaches. M 2 and M 3 mAChR subtypes functionally involved with smooth muscle contraction were shown by molecular and functional studies in the bladder (47, 72) . In human and rat prostate, there is a predominant population of M 1 mAChR subtype present in the glandular epithelium involved in cell proliferation (47, 54) and a predominant population of M 3 mAChRs mediating smooth muscle contraction in the rat ventral prostate (51) . Functional studies demonstrated that postsynaptic M 3 and presynaptic M 1 mAChRs are present in rat vas deferens, and radioligand binding studies suggested a predominant population of M 2 mAChRs in rat vas deferens and epididymis (61, (85) (86) . Although evidence for a direct innervation of Sertoli cells is still lacking, neuronal regulation of Sertoli cell functions has been implicated by findings demonstrating modulation of Sertoli cell functions by neurotransmitters and related molecules (14 -16, 87-89) . The presence of nerve-related proteins such as phosphoneuroprotein (90) and nerve growth factor (91) yields further support for neural regulation of Sertoli cell functions. Taken together, the results of the present study suggest that carbachol stimulation of Sertoli cells triggers different intracellular signaling pathways involving different mAChR subtypes. Considering the fact that different cells are present in rat testes, further immunological studies with selective antibodies against each mAChR subtype will be an important tool to localize and determine the relative importance of mAChRs in rat testes.
In conclusion, the present results provide evidence for the presence of functional mAChR subtypes linked to different intracellular signaling pathways in rat Sertoli cells. The physiological implications of endogenous acetylcholine stimulation of these receptors remain to be clarified.
